Profiel
Ms. Loh Chin-Siew was formerly Head, Pharmaceuticals of the Biomedical Sciences Group at the Singapore Economic Development Board (EDB) where she was involved in developing strategies for the pharmaceuticals sector, and led the promotion efforts to encourage investments from global pharmaceutical companies.
Her principle areas of focus have been R&D and manufacturing, where she and her team successfully negotiated and secured several strategic investments in corporate R&D centres and manufacturing.
Ms. Loh completed her MBA at INSEAD in 2000.
At undergraduate level, she graduated with First Class Honours in Chemistry from the University of Bristol
Eerdere bekende functies van Loh Chin Siew
Bedrijven | Functie | Einde |
---|---|---|
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Directeur/Bestuurslid | - |
Singapore Economic Development Board | Corporate Officer/Principal | - |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Private Equity Investor | - |
Opleiding van Loh Chin Siew
INSEAD | Masters Business Admin |
University of Bristol | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Singapore Economic Development Board | Government |
Bio*One Capital Pte Ltd.
Bio*One Capital Pte Ltd. Investment ManagersFinance Bio*One Capital Pte Ltd (Bio*One Capital) is a venture capital subsidiary of EDB Investments Pte Ltd founded in 1991. The firm is headquartered in Singapore. | Finance |
ProTherapeutics Pte Ltd.
ProTherapeutics Pte Ltd. BiotechnologyHealth Technology ProTherapeutics Pte Ltd. develops new drugs from proteins. It also offers bioactive peptides, which are derived from snake venom toxins and human proteins for tumor regression, macular degeneration, diabetic retinopathy, anti-hypertension, anti-inflammation, hypolocomotion effect, and clot initiation. The company was founded by Ruowen Ge, Peter Wong Tsun Hon, and R. Manjunatha Kini in April 2005 and is headquartered in Singapore. | Health Technology |